Company news

BRAIN Biotech AG news in 2026

BRAIN Biotech AG's news releases, calls and decks from 2026, newest first.

View company

BRAIN Biotech AG Receives EUR 11.51 Million Major Milestone Payment from Royalty Pharma

September 9, 2026

BRAIN Biotech reports its 9M results and continues to target a break-even adjusted Group-EBITDA

August 27, 2026

Dr. Sven K. Weber Succeeds Adriaan Moelker as CEO of BRAIN Biotech AG

July 29, 2026

BRAIN Biotech AG signs new Revolving Credit Facility with MP Beteiligungs-GmbH

July 13, 2026

BRAIN Biotech AG reports half-year figures for fiscal year 2025/26 and confirms full year guidance

May 28, 2026

BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology

March 23, 2026

Results of the 2026 Annual General Meeting for the 2024/25 Financial Year of BRAIN Biotech AG

March 11, 2026

BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase® Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds

February 25, 2026

BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds

February 25, 2026

FY 2024/25: BRAIN Biotech AG benefits from successful monetization of projects and strong corporate cost control

January 14, 2026

Decks in 2026